Cargando…

Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children

BACKGROUND: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma with poor prognosis in children. The 5-year survival rate for early RMS has improved, whereas it remains unsatisfactory for advanced patients. Urine can rapidly reflect changes in the body and identify low-abundance proteins....

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Na, Yu, Yuncui, Duan, Chao, Wei, Jing, Sun, Wei, Jiang, Chiyi, Jian, Binglin, Cao, Wang, Jia, Lulu, Ma, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012572/ https://www.ncbi.nlm.nih.gov/pubmed/36918772 http://dx.doi.org/10.1186/s12014-023-09401-4

Ejemplares similares

Proteomic analysis of urine reveals biomarkers for the diagnosis and phenotyping of abdominal-type Henoch-Schonlein purpura
por: Jia, Lulu, et al.
Publicado: (2021)

Rhabdomyosarcoma of Urinary Bladder
por: Priyadarshi, Vinod, et al.
Publicado: (2014)

Quantitative proteomics for identifying biomarkers for Rabies
por: Venugopal, Abhilash K, et al.
Publicado: (2013)

Quantitative proteomics for identifying biomarkers for tuberculous meningitis
por: Kumar, Ghantasala S Sameer, et al.
Publicado: (2012)

CD56–chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma: A 3.5-year follow-up case report
por: Jiang, Chiyi, et al.
Publicado: (2019)

Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma
por: Lu, Suying, et al.
Publicado: (2020)

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma
por: Cai, Xu‐Wei, et al.
Publicado: (2018)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis and Phenotyping of Carotid Artery Stenosis
por: Wang, Wei, et al.
Publicado: (2021)

Clinical features and prognosis of paediatric rhabdomyosarcoma with bone marrow metastasis: a single Centre experiences in China
por: Huang, Cheng, et al.
Publicado: (2021)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease
por: Sun, Yue, et al.
Publicado: (2020)

Fast quantitative urinary proteomic profiling workflow for biomarker discovery in kidney cancer
por: Lin, Lin, et al.
Publicado: (2018)

Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis
por: Chen, Hongyu, et al.
Publicado: (2022)

Case report: Clinical features and prognosis of two Infants with rhabdomyosarcoma of the tongue
por: Yang, Peiyi, et al.
Publicado: (2023)

A novel potential inflammation-nutrition biomarker for predicting lymph node metastasis in clinically node-negative colon cancer
por: Duan, Wanyao, et al.
Publicado: (2023)

Prostatic rhabdomyosarcoma revealed by acute urinary retention
por: Sakly, Aymen, et al.
Publicado: (2020)

Genito-urinary rhabdomyosarcoma—challenges and controversies for the urologist
por: Bortnick, Eric, et al.
Publicado: (2020)

Label-Free Quantitative Proteomics Identifies Novel Plasma Biomarkers for Distinguishing Pulmonary Tuberculosis and Latent Infection
por: Sun, Huishan, et al.
Publicado: (2018)

Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging
por: Vanarsa, Kamala, et al.
Publicado: (2023)

An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma
por: Kumar, Vipin, et al.
Publicado: (2020)

Quantitative proteomics approach reveals novel biomarkers and pathological mechanism of keloid
por: Liu, Jian, et al.
Publicado: (2022)

Alveolar rhabdomyosarcoma with bone marrow metastasis causes disseminated intravascular coagulation
por: Su, Yan, et al.
Publicado: (2019)

Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
por: Sequeiros, Tamara, et al.
Publicado: (2016)

Effects of Three Commonly-used Diuretics on the Urinary Proteome
por: Li, Xundou, et al.
Publicado: (2014)

Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma
por: Xia, Tian, et al.
Publicado: (2021)

Clinical Proteomics Identifies Urinary CD14 as a Potential Biomarker for Diagnosis of Stable Coronary Artery Disease
por: Lee, Min-Yi, et al.
Publicado: (2015)

Rhabdomyosarcoma of the urinary bladder in an adult: Case report and review of the literature
por: Knowles, Kurt J., et al.
Publicado: (2022)

Nectin2 influences cell apoptosis by regulating ANXA2 expression in neuroblastoma: Nectin2 influences SH-SY5Y cell migration and apoptosis
por: Zhang, Shihan, et al.
Publicado: (2023)

Urinary Proteomics Analysis of Active Vitiligo Patients: Biomarkers for Steroid Treatment Efficacy Prediction and Monitoring
por: Qian, Yue-Tong, et al.
Publicado: (2022)

An individual urinary proteome analysis in normal human beings to define the minimal sample number to represent the normal urinary proteome
por: Liu, Xuejiao, et al.
Publicado: (2012)

Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms
por: Sun, Shenghong, et al.
Publicado: (2020)

UPLC-MS based integrated plasma proteomic and metabolomic profiling of TSC-RAML and its relationship with everolimus treatment
por: Wang, Zhan, et al.
Publicado: (2023)

Rhabdomyosarcoma: Advances in Molecular and Cellular Biology
por: Sun, Xin, et al.
Publicado: (2015)

Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2022)

Quantitative proteomics identified a novel invasion biomarker associated with EMT in pituitary adenomas
por: Zhang, Yu, et al.
Publicado: (2023)

Serum proteomics identify potential biomarkers for nasopharyngeal carcinoma sensitivity to radiotherapy
por: Zhang, Guangying, et al.
Publicado: (2019)

A potential novel inflammation biomarker for predicting the prognosis of decompensated liver cirrhosis
por: Xie, Yanan, et al.
Publicado: (2022)

Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target
por: Puttamallesh, Vinuth N., et al.
Publicado: (2020)

Prognostic nutritional index: A potential biomarker for predicting the prognosis of decompensated liver cirrhosis
por: Xie, Yanan, et al.
Publicado: (2023)

Prostate Rhabdomyosarcoma presenting as acute urinary retention in a young adult
por: Domínguez, Ana, et al.
Publicado: (2022)

Quantitative proteomic analysis of urinary exosomes in kidney stone patients
por: Wang, Qing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nhtccahrt8t5tkmuuc4stc02uu